366 related articles for article (PubMed ID: 21412069)
21. Clinicopathological Aspects and Diagnostic Problems in Patients with Intraductal Papillary Neoplasm of the Bile Duct.
Nanashima A; Imamura N; Sumida Y; Hiyoshi M; Hamada T; Nagayasu T
Anticancer Res; 2018 Apr; 38(4):2343-2352. PubMed ID: 29599359
[TBL] [Abstract][Full Text] [Related]
22. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.
Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS
Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756
[TBL] [Abstract][Full Text] [Related]
23. Frequency of subtypes of biliary intraductal papillary mucinous neoplasm and their MUC1, MUC2, and DPC4 expression patterns differ from pancreatic intraductal papillary mucinous neoplasm.
Sclabas GM; Barton JG; Smyrk TC; Barrett DA; Khan S; Kendrick ML; Reid-Lombardo KM; Donohue JH; Nagorney DM; Que FG
J Am Coll Surg; 2012 Jan; 214(1):27-32. PubMed ID: 22112419
[TBL] [Abstract][Full Text] [Related]
24. Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver.
Shimonishi T; Zen Y; Chen TC; Chen MF; Jan YY; Yeh TS; Nimura Y; Nakanuma Y
Hum Pathol; 2002 May; 33(5):503-11. PubMed ID: 12094375
[TBL] [Abstract][Full Text] [Related]
25. Intraductal oncocytic papillary neoplasm of the bile duct: clinicopathologic and immunohistochemical characteristics of 6 cases.
Tanaka M; Fukushima N; Noda N; Shibahara J; Kokudo N; Fukayama M
Hum Pathol; 2009 Nov; 40(11):1543-52. PubMed ID: 19540556
[TBL] [Abstract][Full Text] [Related]
26. Gallbladder papillary neoplasms share pathological features with intraductal papillary neoplasm of the bile duct.
Wan X; Shi J; Wang A; Xie Y; Yang X; Zhu C; Zhang H; Wu L; Wang S; Huang H; Lin J; Zheng Y; Liang Z; Sang X; Zhao H
Oncotarget; 2017 May; 8(19):31532-31539. PubMed ID: 28415560
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors.
Sasaki M; Sato Y
Hum Pathol; 2017 Apr; 62():152-159. PubMed ID: 28089541
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
29. Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI.
Lee S; Kim MJ; Kim S; Choi D; Jang KT; Park YN
J Hepatol; 2019 Apr; 70(4):692-699. PubMed ID: 30553839
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological features of "intraductal papillary neoplasm of the bile duct" and patient outcome after surgical resection.
Nanashima A; Kinoshita N; Nakanuma Y; Zen Y; Sumida Y; Abo T; Hidaka S; Takeshita H; Yasutake T; Hayashi T; Nagayasu T
Hepatogastroenterology; 2008; 55(85):1167-73. PubMed ID: 18795651
[TBL] [Abstract][Full Text] [Related]
31. Establishment of a novel cell line from intraductal papillary neoplasm of the bile duct.
Murakami S; Ajiki T; Hori Y; Okazaki T; Fukumoto T; Ku Y
Anticancer Res; 2014 May; 34(5):2203-9. PubMed ID: 24778022
[TBL] [Abstract][Full Text] [Related]
32. Biliary intraductal papillary mucinous neoplasia: three case reports.
Yaman B; Nart D; Yilmaz F; Coker A; Zeytunlu M; Kilic M
Virchows Arch; 2009 May; 454(5):589-94. PubMed ID: 19347361
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct.
Sasaki M; Matsubara T; Yoneda N; Nomoto K; Tsuneyama K; Sato Y; Nakanuma Y
Histopathology; 2013 Feb; 62(3):446-57. PubMed ID: 23163606
[TBL] [Abstract][Full Text] [Related]
34. GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct.
Sasaki M; Matsubara T; Nitta T; Sato Y; Nakanuma Y
PLoS One; 2013; 8(12):e81706. PubMed ID: 24312577
[TBL] [Abstract][Full Text] [Related]
35. Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms.
Shibahara H; Tamada S; Goto M; Oda K; Nagino M; Nagasaka T; Batra SK; Hollingsworth MA; Imai K; Nimura Y; Yonezawa S
Am J Surg Pathol; 2004 Mar; 28(3):327-38. PubMed ID: 15104295
[TBL] [Abstract][Full Text] [Related]
36. Prognostic delineation of papillary cholangiocarcinoma based on the invasive proportion: a single-institution study with 184 patients.
Onoe S; Shimoyama Y; Ebata T; Yokoyama Y; Igami T; Sugawara G; Nakamura S; Nagino M
Surgery; 2014 Feb; 155(2):280-91. PubMed ID: 24287144
[TBL] [Abstract][Full Text] [Related]
37. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy.
Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T
Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860
[TBL] [Abstract][Full Text] [Related]
38. Intraductal tubulopapillary neoplasm of the bile duct: potential origin from peribiliary cysts.
Zen Y; Amarapurkar AD; Portmann BC
Hum Pathol; 2012 Mar; 43(3):440-5. PubMed ID: 21813159
[TBL] [Abstract][Full Text] [Related]
39. Morphological classification of intraductal papillary neoplasm of the bile duct.
Ying S; Ying M; Liang W; Wang Z; Wang Q; Chen F; Xiao W
Eur Radiol; 2018 Apr; 28(4):1568-1578. PubMed ID: 29138880
[TBL] [Abstract][Full Text] [Related]
40. The expression of MUC mucin in cholangiocarcinoma.
Mall AS; Tyler MG; Ho SB; Krige JE; Kahn D; Spearman W; Myer L; Govender D
Pathol Res Pract; 2010 Dec; 206(12):805-9. PubMed ID: 20947262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
